메뉴 건너뛰기




Volumn 14, Issue 1, 2015, Pages

Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: A retrospective analysis based on 229,042 patients with type 2 diabetes mellitus

Author keywords

Diabetes related events; Macrovascular event risk; Mortality risk of type 2 diabetes mellitus patients, HbA1C; Type 2 diabetes mellitus

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

EID: 84924288618     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-015-0179-2     Document Type: Article
Times cited : (25)

References (42)
  • 3
    • 77955514902 scopus 로고    scopus 로고
    • Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction-a nationwide study
    • Norgaard ML, Andersen SS, Schramm TK, Folke F, Jørgensen CH, Hansen ML, et al. Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction-a nationwide study. Diabetologia. 2010;53(8):1612-9.
    • (2010) Diabetologia , vol.53 , Issue.8 , pp. 1612-1619
    • Norgaard, M.L.1    Andersen, S.S.2    Schramm, T.K.3    Folke, F.4    Jørgensen, C.H.5    Hansen, M.L.6
  • 4
    • 38349102796 scopus 로고    scopus 로고
    • Diabetes complications severity index and risk of mortality, hospitalisation, and healthcare utilization
    • Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, et al. Diabetes complications severity index and risk of mortality, hospitalisation, and healthcare utilization. Am J Manag Care. 2008;14(1):15-23.
    • (2008) Am J Manag Care , vol.14 , Issue.1 , pp. 15-23
    • Young, B.A.1    Lin, E.2    Korff, M.3    Simon, G.4    Ciechanowski, P.5    Ludman, E.J.6
  • 5
    • 84872290285 scopus 로고    scopus 로고
    • Validating the adapted Diabetes Complications Severity Index in claims data
    • Chang HY, Weiner JP, Richards TM, Bleich SN, Segal JB. Validating the adapted Diabetes Complications Severity Index in claims data. Am J Manag Care. 2012;18(11):721-6.
    • (2012) Am J Manag Care , vol.18 , Issue.11 , pp. 721-726
    • Chang, H.Y.1    Weiner, J.P.2    Richards, T.M.3    Bleich, S.N.4    Segal, J.B.5
  • 6
    • 77950511412 scopus 로고    scopus 로고
    • Executive summary: standards of medical care in diabetes-2010
    • American Diabetes Association. Executive summary: standards of medical care in diabetes-2010. Diabetes Care. 2010;33(S1):S4-10.
    • (2010) Diabetes Care , vol.33 , Issue.S1 , pp. S4-10
  • 7
    • 84898540957 scopus 로고    scopus 로고
    • Global guideline for type 2 diabetes
    • International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):1-52.
    • (2014) Diabetes Res Clin Pract , vol.104 , Issue.1 , pp. 1-52
  • 8
    • 84924320137 scopus 로고    scopus 로고
    • Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes - Langfassung, 1. Auflage. Version 1 2013., accessed 19 December 2013]
    • Bundesärztekammer (BäK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes - Langfassung, 1. Auflage. Version 1 2013. [ http://www.versorgungsleitlinien.de/themen/diabetes2/dm2_Therapie , accessed 19 December 2013]
  • 9
    • 79956193637 scopus 로고    scopus 로고
    • High-normal HbA1c is a strong predictor of type 2 diabetes in the general population
    • Bonora E, Kiechl S, Mayr A, Zoppini G, Targher G, Bonadonna RC, et al. High-normal HbA1c is a strong predictor of type 2 diabetes in the general population. Diabetes Care. 2011;34(4):1038-40.
    • (2011) Diabetes Care , vol.34 , Issue.4 , pp. 1038-1040
    • Bonora, E.1    Kiechl, S.2    Mayr, A.3    Zoppini, G.4    Targher, G.5    Bonadonna, R.C.6
  • 10
    • 84857634590 scopus 로고    scopus 로고
    • Current controversies in the use of haemoglobin A1c
    • Hare MJ, Shaw JE, Zimmet PZ. Current controversies in the use of haemoglobin A1c. J Intern Med. 2012;271(3):227-36.
    • (2012) J Intern Med , vol.271 , Issue.3 , pp. 227-236
    • Hare, M.J.1    Shaw, J.E.2    Zimmet, P.Z.3
  • 11
    • 79955593166 scopus 로고    scopus 로고
    • Implications of using hemoglobin A1C for diagnosing diabetes mellitus
    • Malkani S, Mordes JP. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med. 2011;124(5):395-401.
    • (2011) Am J Med , vol.124 , Issue.5 , pp. 395-401
    • Malkani, S.1    Mordes, J.P.2
  • 12
    • 84876802864 scopus 로고    scopus 로고
    • Health care costs in people with diabetes and their association with glycemic control and kidney function
    • McBrien KA, Manns BJ, Chui B, Klarenbach SW, Rabi D, Ravani P, et al. Health care costs in people with diabetes and their association with glycemic control and kidney function. Diabetes Care. 2013;36(5):1172-80.
    • (2013) Diabetes Care , vol.36 , Issue.5 , pp. 1172-1180
    • McBrien, K.A.1    Manns, B.J.2    Chui, B.3    Klarenbach, S.W.4    Rabi, D.5    Ravani, P.6
  • 13
    • 80052000282 scopus 로고    scopus 로고
    • Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study
    • Huang ES, Liu JY, Moffet HH, John PM, Karter AJ. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34(6):1329-36.
    • (2011) Diabetes Care , vol.34 , Issue.6 , pp. 1329-1336
    • Huang, E.S.1    Liu, J.Y.2    Moffet, H.H.3    John, P.M.4    Karter, A.J.5
  • 14
    • 49449083742 scopus 로고    scopus 로고
    • CHARM Program Investigators. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalisation for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
    • Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, et al. CHARM Program Investigators. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalisation for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med. 2008;168(15):1699-704.
    • (2008) Arch Intern Med , vol.168 , Issue.15 , pp. 1699-1704
    • Gerstein, H.C.1    Swedberg, K.2    Carlsson, J.3    McMurray, J.J.4    Michelson, E.L.5    Olofsson, B.6
  • 15
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-72.
    • (2008) N Engl J Med , vol.358 , Issue.24 , pp. 2560-2572
    • Patel, A.1    MacMahon, S.2    Chalmers, J.3    Neal, B.4    Billot, L.5    Woodward, M.6
  • 16
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-39.
    • (2009) N Engl J Med , vol.360 , Issue.2 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3    Reda, D.4    Emanuele, N.5    Reaven, P.D.6
  • 17
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
    • Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12.
    • (2000) BMJ , vol.321 , Issue.7258 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3    Matthews, D.R.4    Manley, S.E.5    Cull, C.A.6
  • 18
    • 75749145810 scopus 로고    scopus 로고
    • Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study
    • Currie CJ, Peters JR, Tynan A, vans M, Heine RJ, Bracco OL, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375(9713):481-9.
    • (2010) Lancet , vol.375 , Issue.9713 , pp. 481-489
    • Currie, C.J.1    Peters, J.R.2    Tynan, A.3    vans, M.4    Heine, R.J.5    Bracco, O.L.6
  • 19
    • 84884286004 scopus 로고    scopus 로고
    • Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial
    • Hata J, Arima H, Rothwell PM, Woodward M, Zoungas S, Anderson C, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation. 2013;128(12):1325-34.
    • (2013) Circulation , vol.128 , Issue.12 , pp. 1325-1334
    • Hata, J.1    Arima, H.2    Rothwell, P.M.3    Woodward, M.4    Zoungas, S.5    Anderson, C.6
  • 20
    • 78650170501 scopus 로고    scopus 로고
    • What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial
    • Bangalore S, Qin J, Sloan S, Murphy SA, Cannon CP. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation. 2010;122(21):2142-51.
    • (2010) Circulation , vol.122 , Issue.21 , pp. 2142-2151
    • Bangalore, S.1    Qin, J.2    Sloan, S.3    Murphy, S.A.4    Cannon, C.P.5
  • 21
    • 70449360911 scopus 로고    scopus 로고
    • Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial
    • Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, et al. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care. 2009;32(11):2068-74.
    • (2009) Diabetes Care , vol.32 , Issue.11 , pp. 2068-2074
    • Zoungas, S.1    Galan, B.E.2    Ninomiya, T.3    Grobbee, D.4    Hamet, P.5    Heller, S.6
  • 22
    • 84896727396 scopus 로고    scopus 로고
    • Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes - an 11-year follow up study
    • Umamahesh K, Vigneswari A, Surya Thejaswi G, Satyavani K, Viswanathan V. Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes - an 11-year follow up study. Indian Heart J. 2014;66(1):5-10.
    • (2014) Indian Heart J , vol.66 , Issue.1 , pp. 5-10
    • Umamahesh, K.1    Vigneswari, A.2    Surya Thejaswi, G.3    Satyavani, K.4    Viswanathan, V.5
  • 23
    • 78149315855 scopus 로고    scopus 로고
    • Prediction of mortality in patients undergoing maintenance hemodialysis by Charlson Comorbidity Index using ICD-10 database
    • Chae JW, Song CS, Kim H, Lee KB, Seo BS, Kim DI. Prediction of mortality in patients undergoing maintenance hemodialysis by Charlson Comorbidity Index using ICD-10 database. Nephron Clin Pract. 2011;117(4):c379-84.
    • (2011) Nephron Clin Pract , vol.117 , Issue.4 , pp. c379-c384
    • Chae, J.W.1    Song, C.S.2    Kim, H.3    Lee, K.B.4    Seo, B.S.5    Kim, D.I.6
  • 24
    • 84924320136 scopus 로고    scopus 로고
    • Guidelines for ATC classification and DDD assignment, 2014. Oslo: WHO Collaborating Centre for Drug Statistics Methodology
    • WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2014. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2013.
    • (2013)
  • 25
    • 72949106036 scopus 로고    scopus 로고
    • Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study
    • Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854-60.
    • (2009) Ann Intern Med , vol.151 , Issue.12 , pp. 854-860
    • Greenfield, S.1    Billimek, J.2    Pellegrini, F.3    Franciosi, M.4    Berardis, G.5    Nicolucci, A.6
  • 26
    • 58149330590 scopus 로고    scopus 로고
    • Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
    • Ferrannini E, Fonseca V, Zinman B, Matthews D, Ahrén B, Byiers S, et al. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Diabetes Obes Metab. 2009;11(2):157-66.
    • (2009) Diabetes Obes Metab , vol.11 , Issue.2 , pp. 157-166
    • Ferrannini, E.1    Fonseca, V.2    Zinman, B.3    Matthews, D.4    Ahrén, B.5    Byiers, S.6
  • 27
    • 84871158616 scopus 로고    scopus 로고
    • Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis
    • Rathmann W, Kostev K, Gruenberger JB, Dworak M, Bader G, Giani G. Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis. Diabetes Obes Metab. 2013;15(1):55-61.
    • (2013) Diabetes Obes Metab , vol.15 , Issue.1 , pp. 55-61
    • Rathmann, W.1    Kostev, K.2    Gruenberger, J.B.3    Dworak, M.4    Bader, G.5    Giani, G.6
  • 28
    • 84878109037 scopus 로고    scopus 로고
    • The association of obesity with cardiovascular events in patients with peripheral artery disease
    • Cronin O, Morris DR, Walker PJ, Golledge J. The association of obesity with cardiovascular events in patients with peripheral artery disease. Atherosclerosis. 2013;228:316-23.
    • (2013) Atherosclerosis , vol.228 , pp. 316-323
    • Cronin, O.1    Morris, D.R.2    Walker, P.J.3    Golledge, J.4
  • 29
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
    • Turner R, UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-13.
    • (1998) BMJ , vol.317 , Issue.7160 , pp. 703-713
    • Turner, R.1
  • 30
    • 80052964675 scopus 로고    scopus 로고
    • Redefining blood pressure targets in high-risk patients? Lessons from coronary endpoints in recent randomized trials
    • Volpe M, Tocci G. Redefining blood pressure targets in high-risk patients? Lessons from coronary endpoints in recent randomized trials. Am J Hypertens. 2011;24(10):1060-8.
    • (2011) Am J Hypertens , vol.24 , Issue.10 , pp. 1060-1068
    • Volpe, M.1    Tocci, G.2
  • 31
    • 84888622290 scopus 로고    scopus 로고
    • HbA1C for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
    • Kowall B, Rathmann B. HbA1C for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform? Diabetes Metab Syndr Obes. 2013;6:477-91.
    • (2013) Diabetes Metab Syndr Obes , vol.6 , pp. 477-491
    • Kowall, B.1    Rathmann, B.2
  • 32
    • 84890034047 scopus 로고    scopus 로고
    • Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
    • ORIGIN Trial Investigators, Mellbin LG, Rydén L, Riddle MC, Probstfield J, Rosenstock J, et al. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J. 2013;34(40):3137-44.
    • (2013) Eur Heart J , vol.34 , Issue.40 , pp. 3137-3144
    • Mellbin, L.G.1    Rydén, L.2    Riddle, M.C.3    Probstfield, J.4    Rosenstock, J.5
  • 33
    • 79952273819 scopus 로고    scopus 로고
    • Long-term effects of intensive glucose lowering on cardiovascular outcomes
    • The ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364:818-28.
    • (2011) N Engl J Med , vol.364 , pp. 818-828
  • 35
    • 84879819683 scopus 로고    scopus 로고
    • Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study
    • Penno G, Solini A, Zoppini G, Orsi E, Fondelli C, Zerbini G, et al. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol. 2013;12:98.
    • (2013) Cardiovasc Diabetol , vol.12 , pp. 98
    • Penno, G.1    Solini, A.2    Zoppini, G.3    Orsi, E.4    Fondelli, C.5    Zerbini, G.6
  • 36
    • 84923312755 scopus 로고    scopus 로고
    • Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options
    • Du YF, Ou HY, Beverly EA, Chiu CJ. Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options. Clin Interv Aging. 2014;9:1963-80.
    • (2014) Clin Interv Aging , vol.9 , pp. 1963-1980
    • Du, Y.F.1    Ou, H.Y.2    Beverly, E.A.3    Chiu, C.J.4
  • 37
    • 84921359093 scopus 로고    scopus 로고
    • Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study
    • Jiao FF, Fung CS, Wong CK, Wan YF, Dai D, Kwok R, et al. Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study. Cardiovasc Diabetol. 2014;13(1):127.
    • (2014) Cardiovasc Diabetol , vol.13 , Issue.1 , pp. 127
    • Jiao, F.F.1    Fung, C.S.2    Wong, C.K.3    Wan, Y.F.4    Dai, D.5    Kwok, R.6
  • 38
    • 84886013625 scopus 로고    scopus 로고
    • Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up
    • Novo S, Peritore A, Trovato RL, Guarneri FP, Di Lisi D, Muratori I, et al. Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up. Cardiovasc Diabetol. 2013;12(1):155.
    • (2013) Cardiovasc Diabetol , vol.12 , Issue.1 , pp. 155
    • Novo, S.1    Peritore, A.2    Trovato, R.L.3    Guarneri, F.P.4    Lisi, D.5    Muratori, I.6
  • 39
    • 84916918362 scopus 로고    scopus 로고
    • All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: Is there a relationship with the equation used?
    • [Epub ahead of print]
    • Fabbian F, De Giorgi A, Monesi M, et al. All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: Is there a relationship with the equation used? Diab Vasc Dis Res. 2014. [Epub ahead of print]
    • (2014) Diab Vasc Dis Res
    • Fabbian, F.1    De Giorgi, A.2    Monesi, M.3
  • 40
    • 84893477471 scopus 로고    scopus 로고
    • Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register
    • Zethelius B, Gudbjörnsdottir S, Eliasson B, Eeg-Olofsson K, Cederholm J. Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register. Eur J Prev Cardiol. 2014;21(2):244-51.
    • (2014) Eur J Prev Cardiol , vol.21 , Issue.2 , pp. 244-251
    • Zethelius, B.1    Gudbjörnsdottir, S.2    Eliasson, B.3    Eeg-Olofsson, K.4    Cederholm, J.5
  • 42
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    • Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-96.
    • (2004) Lancet , vol.364 , Issue.9435 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3    Hitman, G.A.4    Neil, H.A.5    Livingstone, S.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.